EMA's September 2026 NAM data pilot lets sponsors share organ-chip and computational data directly with regulators, reshaping ...
Veeva Falcon Safety's E2B(R3) interoperability across all input channels signals the end of dual-entry SAE workflows—here's ...
Girl with Griscelli Syndrome Type II receives first haploidentical transplant at Miami hospital, offering new hope for ...
Elevar presents age-stratified camrelizumab-rivoceranib data from Phase 3 CARES-310 after two FDA rejections, signaling ...
PMV Pharma's rezatapopt achieves 44% response rate in TP53 Y220C ovarian cancer patients, positioning the drug for potential ...
Scale AI's CliniCARE-Bench found 34.7% error rates and right-answer-wrong-process failures. The clinical trials field has no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results